Pseudobulbar Affect Treatments

Last updated: 15 March 2022

Pseudobulbar Affect Treatments

You can legally access new medicines, even if they are not approved in your country.

Learn more »

What is Pseudobulbar Affect (PBA)?

Pseudobulbar Affect (PBA) is a neurological condition that causes outbursts of uncontrolled or inappropriate laughing or crying. It is also known by other names including emotional lability, pathological laughing and crying, involuntary emotional expression disorder, compulsive laughing or weeping, or emotional incontinence. PBA is sometimes incorrectly diagnosed as a mood disorder – especially depression or bipolar disorder.1

What are available Pseudobulbar Affect Treatments?

There are not many PBA medications that have been approved.

Nuedexta (dextromethorphan hydrobromide [HBr] and quinidine sulfate) is the first and only FDA-approved treatment for PBA in October 2010.

Nuedexta (dextromethorphan hydrobromide [HBr] and quinidine sulfate) is a nervous system drug indicated for the symptomatic treatment of pseudobulbar affect (PBA) in adults.2

If you are trying to access a Pseudobulbar Affect medication that is approved outside of your country of residence, we might be able to help you access it with the help of your treating doctor. You can read more about the medicine we can help you access and its price below:

Why access a PBA drug with is registered in The Hague with the Dutch Ministry of Health (registration number 6730 BEM) as an independent medicines intermediary. We have helped patients from over 85 countries to access thousands of medicines including. With a prescription from your treating doctor, you can count on our expert team to safely and legally guide you to access medication for pseudobulbar affect. If you or someone you know are looking to access a medicine that is not yet approved where they live, we can support you. Contact us /contact-us for more information.



Disclaimer: This article is not meant to influence or impact the care provided by your treating physician. Please do not make changes to your treatment without first consulting your healthcare provider. This article is not intended to diagnose or treat illness or to influence treatment options. is as diligent as possible in compiling and updating the information on this page. However, does not guarantee the correctness and completeness of the information provided on this page.